以下為蘇正堯教授於近五年內所發表的SCI學術論文:

Virally inactivated human platelet concentrate lysate induces regulatory T cells and immunosuppressive effect in a murine asthma model.
─ Yueh-Lun Lee, Lin-Wen Lee, Chen-Yao Su*, George Hsiao, Yi-Yuan Yang, Sy-Jye Leu, Ying-Hua Shieh,and Thierry Burnouf  Transfusion (Online publication) 2013

Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria.
─ Burnouf, T, Chou ML, Wu YW, Su CY*, Lee LW. Transfusion 2012 %2

Human platelet concentrates: a source of solvent-detergent treated highly enriched brain-derived neurotrophic factor (BDNF).
─ Burnouf T, Kuo YP, Blum D, Burnouf S, Su CY*. Transfusion 2012; 52:1721-1728

Human blood-derived fibrin releasates: composition and use for the culture of cell lines and human primary cells.
─ Burnouf T, Luo CW, Kuo YP, Chou ML, Wu YW, Tseng YH, Su CY* Biologicals 40(2012)21-30

Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria.
─ Burnouf T, Lee CY,Wu YW, Su CY* Vox Sanguinis ; 2012:102:277-284.

Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally-inactivated allogeneic human platelet lysate.
─ Shih DTB, Chen JC, Chen WY, Kuo YP, Su CY*, Burnouf T*.Transfusion 2011%nsfusion 2011;51:770-8.

A chromatographically purified human TGF-β1 fraction from virally inactivated platelet lysates.
─ Burnouf T, Chang CW, Kuo YP, Wu YW, Tseng YH, Su CY* Vox Sanguinis 2011; 101:215-220.

A novel virally-inactivated human platelet lysate preparation rich in TGF-b1, EGF and IGF, depleted of PDGF and VEGF.
─ Burnouf PA, Juan PK, , Kuo YP, Chou ML, Su CH, Tseng YH, Lin CT, Burnouf T, Su CY* Biotechnology & Applied Biochemistry, 2010;56:151-60.

A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets.
─ Burnouf T, Kuo YP, Huang CT, Tseng YH, Lin CT, Su CY.* Transfusion 2010;50:1702-1711

Influence of ethanol on the release of growth factors in human blood-derived platelet gels.
─ Kuo YP, Lee YL, Tseng HT, Su CH, Burnouf T, Su CY* Biologicals. 2010;38 (2010) 120-127

In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF.
─ Su CY,* Kuo YP, Tseng YH, Su CH, Burnouf T. Oral Surg. Oral Med. Oral Pathol Oral Radiol Endod 2009; 108. 56-61

A virally inactivated functional growth factor preparation from human platelet concentrates.
─ Su CY*, Kuo YP, Lin YC, Huang CT, Tseng YH, Burnouf T. Vox Sanguinis 2009;97:119-28

Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom.
─ Segura A, Leon G, Su CY*, Gutierrez JM, Burnouf T. Biologicals, 2009;37:306-12

A virally inactivated functional growth factor preparation from human platelet concentrates.
─ Su CY*, Kuo YP, Lin YC, Huang CT, Tseng YH, Burnouf T. Vox Sanguinis, 2009, 97;119-128.

Blood-derived biomaterials: fibrin sealant, platelet gel and platelet fibrin glue.
─ Burnouf T, Su CY*, Radosevich M, Goubran HA., El-Ekiaby M. ISBT Science Series (2009) 4, 136-142

Solvent/detergent treatment of platelet concentrates enhances the release of growth factors.
─ Burnouf T, Tseng YH, Kuo YP, Su CY*. Transfusion 2009;48:1090-98

Quantitative assessment of the kinetics of growth factors release from platelet gel.
─ Su CY*, Kuo YP, Nieh HL, Tseng YH, Burnouf T. Transfusion 2008; 48:2414-2420

Early experience and results of bone grafts enriched with autologous platelet gel for recalcitrant nonunions of lower extremity.
─ Chiang CC, Su CY*, Huang CK, Chen WM, Chen TU, Tzeng YH. J Trauma 2007;63(3)655-61